Incorrect.
The answer is α‐synuclein.
In a new study, researchers found that α‐synuclein levels in brain-derived blood exosomes can distinguish healthy controls from patients with either Parkinson disease (PD) or multiple system atrophy (MSA) and that those a-synuclein levels can be a way to distinguish PD from MSA.
Read more about the study here.